Clinical Trial Update: Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vaccination in the peripheral stem cell transplant setting for acute myeloid leukemia has completed. Sponsor: Cell Genesys.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Unspecified vaccine for peripheral stem cell transplant setting

Snippet

Sponsor: Cell Genesys | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED